PARIS, July 31, 2014 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014. Chris Viehbacher, CEO of Sanofi, comments on results and outlook.
Watch video interview and read transcript:
http://eurobusinessmedia.com/ceo-direct/sanofi/interview-with-ceo-chris-viehbacher-h1-2014-results,2014-07-30,1235?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- Q2 2014
- FY 2014
- Diabetes
- Genzyme
- Vaccines
- Alirocumab
- Animal Health
- CHC
- R&D
About Sanofi
Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
SOURCE Sanofi
